Research on the Planning Strategy of Jingzhou Characteristic Villages Under the Background of Rural Revitalization
Studies in Art and Architecture · 2023
DOI: 10.56397/saa.2023.03.05 ↗Kurz gefasst
Fachartikel in der Zeitschrift Studies in Art and Architecture, 2023. Verfasst von Bo Pan und 2 weiteren Autor:innen.
Abstract (Originalsprache)
The 19th National Congress of the Communist Party of China put forward the strategy of rural revitalization, and the construction of beautiful and characteristic villages has entered a new stage. Jingzhou characteristic rural planning as a regional strategy, its purpose is to promote the special process of Jingzhou countryside better, to achieve Jingzhou rural revitalization. Through the analysis of the status quo of characteristic village construction under the background of rural revitalization, the status quo of characteristic village construction in our city, the basic principles and tasks of planning. From the industry revitalization, cultural revitalization, ecological revitalization, talent revitalization and organizational revitalization of five aspects of Jingzhou characteristics of rural planning strategy. Open up a rural development road with Jingzhou characteristics, and enrich the practical connotation of characteristic rural construction.
Zitieren
APA
Pan, B., Tian, C., & Qin, Z. (2023). Research on the Planning Strategy of Jingzhou Characteristic Villages Under the Background of Rural Revitalization. Studies in Art and Architecture. https://doi.org/10.56397/saa.2023.03.05
Vancouver
Pan B, Tian C, Qin Z. Research on the Planning Strategy of Jingzhou Characteristic Villages Under the Background of Rural Revitalization. Studies in Art and Architecture. 2023. doi:10.56397/saa.2023.03.05
BibTeX
@article{Pan2023,
author = {Pan, Bo and Tian, Congxiang and Qin, Zhiwei},
title = {Research on the Planning Strategy of Jingzhou Characteristic Villages Under the Background of Rural Revitalization},
journal = {Studies in Art and Architecture},
year = {2023},
doi = {10.56397/saa.2023.03.05}
}
EUVIMED